Lexeo Therapeutics, Inc.
LXEO
$5.09
-$0.41-7.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 93.37% | 49.58% | -21.82% | -24.05% | -48.82% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 43.65% | 43.93% | 106.28% | 230.67% | 79.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 90.80% | 49.37% | -19.86% | -20.94% | -46.86% |
|
|
|||||
| Total Current Assets | 90.80% | 49.37% | -19.86% | -20.94% | -46.86% |
| Net Property, Plant & Equipment | -17.64% | -16.10% | -15.62% | -15.95% | -14.59% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -0.12% | -0.12% | -0.12% | -0.12% |
| Total Assets | 99.19% | 82.85% | -17.27% | -8.30% | -41.05% |
|
|
|||||
| Total Accounts Payable | -72.16% | -24.33% | -44.82% | 247.35% | 178.82% |
| Total Accrued Expenses | -48.11% | -30.35% | -36.01% | -14.64% | 7.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.81% | 0.19% | 1.23% | -0.52% | 1.38% |
| Total Finance Division Other Current Liabilities | -84.60% | -86.61% | -62.27% | -15.45% | 105.21% |
| Total Other Current Liabilities | -84.60% | -86.61% | -62.27% | -15.45% | 105.21% |
| Total Current Liabilities | -53.97% | -26.43% | -35.60% | 67.36% | 42.50% |
|
|
|||||
| Total Current Liabilities | -53.97% | -26.43% | -35.60% | 67.36% | 42.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -30.84% | -28.16% | -25.63% | -23.53% | -21.72% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -49.81% | -26.85% | -33.37% | 39.88% | 24.19% |
|
|
|||||
| Common Stock & APIC | 57.60% | 57.79% | 21.95% | 22.44% | 3.76% |
| Retained Earnings | -27.97% | -35.68% | -41.28% | -50.80% | -53.71% |
| Treasury Stock & Other | -123.94% | 242.50% | 653.85% | -130.77% | -- |
| Total Common Equity | 162.72% | 111.11% | -13.27% | -16.21% | -51.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 162.72% | 111.11% | -13.27% | -16.21% | -51.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 162.72% | 111.11% | -13.27% | -16.21% | -51.84% |
|
|
|||||